Mumbai: Ashutosh Inamdar has been promoted to CEO of Lupin Life Sciences Limited (LLSL). Lupin has announced the formation of Lupin Life Sciences Limited (LLSL), focusing on the Trade Generics segment. This move aims to enhance Lupin’s presence in the fast-growing Trade Generics market by offering high-quality, affordable drugs to patients.
Inamdar has been with Lupin for nearly nine years, holding various senior positions. His recent roles include Senior General Manager of Lupin Generics Business and Senior General Manager of the Strategy Cell. In these roles, he has been instrumental in shaping Lupin’s digital strategy and leading innovation initiatives. His focus on leveraging technology and real-time data analytics has significantly improved business processes and customer engagement. Prior to joining Lupin, Inamdar held strategic roles at Mahindra & Mahindra, Gammon India Ltd, Infrasoft Technologies, and Verizon.
His experience includes business planning, corporate strategy, commercial negotiations, and operational excellence. Inamdar holds a PGDM from the Indian Institute of Management, Indore, and a B.E. in Electronics and Telecommunication from Pune Institute of Computer Technology.
